Press releases
Press releases are available from 1999, when MVI was established as a program at PATH, to the present.
2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004–2002 | 2001–1999
- PATH welcomes positive steps on price, donations for GlaxoSmithKline's RTS,S malaria vaccine candidate
20 January 2010 - First steps taken toward the development of a malaria transmission-blocking vaccine
15 January 2010 (41 KB PDF)
- Scientists to discuss transmission-blocking vaccines and their role in malaria eradication
17 November 2009 (24 KB PDF) - World's largest malaria vaccine trial now underway in seven African countries
3 November 2009 (46 KB PDF) - PATH Malaria Vaccine Initiative shares strategy for developing "next-generation" malaria vaccines
2 November 2009 (28 KB PDF) - MVI and Crucell announce collaboration to test new adenovirus-based malaria vaccine approach
29 July 2009 (63 KB PDF) - Phase 1 trial of whole-parasite malaria vaccine to begin
23 April 2009 (49 KB PDF)
- New collaboration builds on recent malaria antigen discovery
26 February 2009 (20 KB PDF)
- Two new studies in the New England Journal of Medicine show malaria vaccine candidate advancing in Africa
8 December 2008 (166 KB PDF)
- The PATH Malaria Vaccine Initiative announces collaboration with US Food and Drug Administration
25 September 2008 (43 KB PDF) - Dr. Santiago Ferro named Director of Clinical Development at PATH Malaria Vaccine Initiative
18 August 2008 (21 KB PDF) - PATH Malaria Vaccine Initiative (MVI) joins in launch of dedicated malaria vaccine manufacturing facility
19 June 2008 (51 KB PDF) - MVI Director Christian Loucq issues a congratulatory statement to the recipients of the Prince of Asturias Foundation Award for International Cooperation
5 June 2008 (20 KB PDF) - The PATH Malaria Vaccine Initiative (MVI) observes the first World Malaria Day with a sense of optimism
24 April 2008 (20 KB PDF) - Participants of the International Malaria Conference, strongly commit to the fight against malaria and poverty
21 April 2008 (76 KB PDF) - PATH Malaria Vaccine Initiative, Seattle Biomedical Research Institute
accelerate search for malaria vaccine by expanding "human challenge" tests
5 March 2008 (33 KB PDF) - Intercell (ICLL) and the PATH Malaria Vaccine Initiative announce new collaboration for a vaccine against malaria
16 January 2008 (235 KB PDF) - Ashley Birkett appointed Director, Preclinical Research and Development, at the PATH Malaria Vaccine Initiative
14 January 2008 (30 KB PDF)
- Sanaria, PATH Malaria Vaccine Initiative open manufacturing facility for producing world's first "whole-parasite" malaria vaccine
26 October 2007 (45 KB PDF) - New Lancet study: malaria vaccine candidate has promising safety, tolerability profile in infants; first “proof of concept” of world’s most advanced malaria vaccine candidate in African infants shows protection against malaria
17 October 2007 (80 KB PDF) - Nouvelle étude publiée dans The Lancet : le vaccin candidat antipaludéen le plus avancé au monde présente un profil d’innocuité et de tolérabilité prometteur chez les nourrissons en Afrique; Le premier essai de faisabilité démontre que le vaccin protège les nourrissons en Afrique contre le paludisme
17 October 2007 (79 KB PDF) - Malaria vaccine is safe, immunogenic and efficacious in young infants
17 October 2007 (29 KB PDF) - PATH Malaria Vaccine Initiative names Dr. Christian Loucq director of PATH Malaria Vaccine Initiative
29 May 2007 (24 KB PDF) - PATH Malaria Vaccine Initiative announces new Director of Strategy and Operations: Dr. Christian Loucq
02 February 2007 (52 KB PDF)
- PATH Malaria Vaccine Initiative announces new partnership to accelerate development of novel malaria vaccine candidate
14 December 2006 (40 KB PDF) - John McNeil named scientific director of PATH Malaria Vaccine Initiative
11 October 2006 (38 KB PDF) - New agreement expands clinical testing of a Chinese malaria vaccine candidate
15 March 2006 (30 KB PDF) - African health officials from 13 countries outline decision-making process for inclusion of malaria vaccine in future African vaccine programs
24 January 2006 (40 KB PDF)
ARCHIVES
- New results show the RTS,S malaria vaccine candidate protects children for at least 18 Months
15 November 2005 (45 KB PDF) - New Gates funding will enable MVI and GSK Biologicals to complete development of world’s most advanced malaria vaccine candidate
30 October 2005 (30 KB PDF) - The PATH Malaria Vaccine Initiative welcomes ExxonMobil grant to speed malaria vaccine development
26 September 2005 (38 KB PDF) - The PATH Malaria Vaccine Initiative welcomes President Bush's new initiative on malaria
01 July 2005 (30 KB PDF)
- Public-private partnership leads to scientific breakthrough in malaria vaccine development
14 October 2004 (36 KB PDF) - GenVec, U.S. Naval Medical Research Center and PATH's Malaria Vaccine Initiative Partner to expand malaria vaccine efforts
31 March 2004 (36 KB PDF) - Malaria Vaccine Initiative receives $100 million from Bill & Melinda Gates Foundation
21 September 2003 (31 KB PDF) - Clinical trial of advanced malaria vaccine candidate to begin in Mozambique
8 July 2003 (35 KB PDF) - Cross-Atlantic partnership launches study to project the future impact of malaria vaccines
8 July 2003 (35 KB PDF) - MVI observes Africa Malaria Day
25 April 2003 (32 KB PDF) - Malaria Vaccine Initiative gets new leadership
30 Jan 2003 (32 KB PDF) - New findings in malaria vaccine development announced at international malaria conference
19 November 2002 (54 KB PDF) - Clinical trial of advanced malaria vaccine candidate begins in Mozambique
01 July 2002 (36 KB PDF) - Malaria Vaccine Initiative supports far-reaching senate effort aimed at fighting AIDS, malaria, and TB
17 May 2002 (31 KB PDF) - U.S. Army joins forces with Malaria Vaccine Initiative to launch clinical trial in Kenya
25 April 2002 (36 KB PDF)
- Australia's preeminent malaria scientists to collaborate with the Malaria Vaccine Initiative
17 December 2001 (41 KB PDF) - Clinical trials of advanced malaria vaccine candidate expand to Mozambique
05 December 2001 (31 KB PDF) - Malaria Vaccine Initiative, Oxford University, and Oxxon Pharmaccines to accelerate clinical development of innovative malaria vaccine
22 October 2001 (36 KB PDF) - India-US join forces to combat world's most widespread form of malaria
11 July 2001 (31 KB PDF) - Three malaria vaccine development donors join forces
22 June 2001 (35 KB PDF) - Key vaccine trial in children begins in The Gambia
25 April 2001 (34 KB PDF) - MVI and GlaxoSmithKline partner to develop malaria vaccine for children in Africa
1 March 2001 (37 KB PDF) - MVI and Apovia, Inc. partner to pursue rapid development of a novel malaria vaccine
25 January 2001 (32 KB PDF) - MVI and Yerkes Regional Primate Research Center/Emory University team up to test candidate malaria vaccines for safety
10 January 2001 (31 KB PDF) - NIAID and the Malaria Vaccine Initiative/PATH sign agreement to accelerate malaria vaccine research
11 February 2000 (36 KB PDF) - The William H. Gates Foundation Announces a $50 Million Gift to establish the Malaria Vaccine Initiative
2 June 1999 (35 KB PDF)
